NectinTx
3 known investors
Find your way into NectinTx
Nectin Therapeutics develops novel monoclonal antibodies and antibody-drug-conjugates to treat difficult-to-treat cancers by targeting immune evasion mechanisms. The company is a biotech firm with a pipeline focused on oncology immunotherapy, including its lead candidate NTX1088 currently in clinical trials.
Investors · 3
Frequently asked questions
- What does NectinTx do?
- Nectin Therapeutics develops novel monoclonal antibodies and antibody-drug-conjugates to treat difficult-to-treat cancers by targeting immune evasion mechanisms. The company is a biotech firm with a pipeline focused on oncology immunotherapy, including its lead candidate NTX1088 currently in clinical trials.
- Who are NectinTx's investors?
- NectinTx's investors include Peregrine Ventures, Cancer Focus, Israel Biotech Fund.